Level, phenotype and activation status of CD4+FoxP3+regulatory T cells in patients chronically infected with human immunodeficiency virus and/or hepatitis C virus
about
FOXP3 expression is upregulated in CD4T cells in progressive HIV-1 infection and is a marker of disease severity.Lung T-cell subset composition at the time of surgical resection is a prognostic indicator in non-small cell lung cancer.Quantification of hepatic FOXP3+ T-lymphocytes in HIV/hepatitis C coinfection.Association of chronic hepatitis C infection with T-cell phenotypes in HIV-negative and HIV-positive women.Multi-analyte profiling of ten cytokines in South African HIV-infected patients with Immune Reconstitution Inflammatory Syndrome (IRIS).Immune activation response in chronic HIV-infected patients: influence of Hepatitis C virus coinfection.Increased frequency of regulatory T cells accompanies increased immune activation in rectal mucosae of HIV-positive noncontrollers.CD4+FOXP3+ Regulatory T-Cell Subsets in Human Immunodeficiency Virus Infection.A coat of many colors: neuroimmune crosstalk in human immunodeficiency virus infection.Early and long-lasting alteration of effector CD45RA(-)Foxp3(high) regulatory T-cell homeostasis during HIV infection.Persistence of Protective Hepatitis B Surface Antibody Titers after Successful Double-Dose Hepatitis B Virus Rescue Vaccination in HIV-Infected Patients.Regulation of antiviral CD8 T-cell responsesPhenotypical characterization of regulatory T cells in humans and rodents.Phenotypic characterization of regulatory T cells from antiretroviral-naive HIV-1-infected people.Association between discordant immunological response to highly active anti-retroviral therapy, regulatory T cell percentage, immune cell activation and very low-level viraemia in HIV-infected patients.HCV viraemia associates with NK cell activation and dysfunction in antiretroviral therapy-treated HIV/HCV-co-infected subjects.Forkhead box protein 3(+) regulatory T cells and Helios(+) subset in perinatally acquired HIV.Induction of Multiple Immune Regulatory Pathways with Differential Impact in HCV/HIV Coinfection.Chronically HIV-1 Infected Patients Exhibit Low Frequencies of CD25+ Regulatory T Cells.Altered phenotype of regulatory T cells associated with lack of human immunodeficiency virus (HIV)-1-specific suppressive function.Therapeutic Potential of Gene-Modified Regulatory T Cells: From Bench to Bedside.CD4+ and CD8+ Regulatory T Cells (Tregs) are Elevated and Display an Active Phenotype in Patients with Chronic HCV Mono-Infection and HIV/HCV Co-Infection
P2860
Q33644550-A2F836C9-8355-4AC3-93EA-8D9081399EFBQ34132958-EE450F07-87C5-4404-8ECC-349BFA6C5720Q34157353-4CD80DE8-7A60-47E2-AD4E-7A5417305F93Q34340862-285F6A5B-9E55-4362-B050-9DB2922F96B2Q34350857-638B7C70-CC82-4763-BB8B-03CBF5F418B9Q35182200-D615F80E-BE74-4E57-A271-64194C0CEAECQ35363011-92EDF83C-E60C-4F63-A8AA-38DEF768DC7FQ37054806-E8455AF6-01D3-46FB-95F4-DDFB7E78CF0EQ37617639-A4C3BF84-C48E-4B6D-8BE6-A8DA9F05393EQ37706839-7A4EBBDF-3548-4C40-82A5-823ECF7B0F5CQ37989146-AB9166DF-F80B-4212-98E9-ADB239CE9F65Q38165191-F00AE7D8-C94F-4C86-B4E3-52B99AA98EFBQ38819911-90B0170F-729F-4944-A5DE-8FF5B8A0C1D0Q38856175-896F8134-504D-463F-8664-8D54AD5D6C74Q39422439-2299EA76-3A2C-43A9-8C6E-83B2A659A2ADQ40238137-391DAA82-BDA8-4C84-B8CF-E5F1E5055FD6Q41648040-43D87432-E14C-406A-A5E8-E97675AEEBA1Q41856139-63F81347-48C4-4169-8462-5D8648D236D0Q42157400-1E19FBC2-56F3-4E36-B693-314A703237AFQ45362664-2D59FF0F-67D0-43E6-84A8-EE4F06983088Q52674851-11C1533A-9219-436C-870F-FE1FB3C55FBEQ57609524-91267ED7-2BA0-46A6-8D03-A414563F89D7
P2860
Level, phenotype and activation status of CD4+FoxP3+regulatory T cells in patients chronically infected with human immunodeficiency virus and/or hepatitis C virus
description
2009 nî lūn-bûn
@nan
2009 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Level, phenotype and activatio ...... virus and/or hepatitis C virus
@ast
Level, phenotype and activatio ...... virus and/or hepatitis C virus
@en
Level, phenotype and activatio ...... virus and/or hepatitis C virus
@nl
type
label
Level, phenotype and activatio ...... virus and/or hepatitis C virus
@ast
Level, phenotype and activatio ...... virus and/or hepatitis C virus
@en
Level, phenotype and activatio ...... virus and/or hepatitis C virus
@nl
prefLabel
Level, phenotype and activatio ...... virus and/or hepatitis C virus
@ast
Level, phenotype and activatio ...... virus and/or hepatitis C virus
@en
Level, phenotype and activatio ...... virus and/or hepatitis C virus
@nl
P2093
P2860
P1476
Level, phenotype and activatio ...... virus and/or hepatitis C virus
@en
P2093
J García-Samaniego
J González-Lahoz
J M Benito
N I Rallón
P García-Gasco
P2860
P356
10.1111/J.1365-2249.2008.03797.X
P577
2009-01-01T00:00:00Z